This comparative matched-cohort study aims to evaluate the diagnostic performance of contrast-enhanced photon-counting computed tomography (PCCT) for detecting small gastrointestinal lesions compared with energy-integrating detector dual-energy computed tomography (DECT). The study includes a prospectively enrolled PCCT cohort and a retrospectively identified DECT cohort. Endoscopy with histopathology serves as the reference standard. Primary evaluation focuses on lesion detection, with additional assessment of lesion characterization, image quality, quantitative imaging parameters, and interobserver agreement.
Study Type
OBSERVATIONAL
Enrollment
1,762
Contrast-enhanced abdominal photon-counting computed tomography performed for the detection and characterization of small gastrointestinal lesions.
Contrast-enhanced abdominal energy-integrating detector dual-energy computed tomography performed for comparison of diagnostic performance in detecting and characterizing small gastrointestinal lesions.
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Lesion-Based Detection Rate
Lesion-based detection rate of contrast-enhanced photon-counting CT compared with energy-integrating detector dual-energy CT using endoscopy with histopathology, when available, as the reference standard.
Time frame: During the study period (January 2026 - March 2026)
Positive Predictive Value of CT-Positive Findings
Patient-level positive predictive value (PPV) of CT-positive findings for small gastrointestinal lesions detected on contrast-enhanced photon-counting CT (PCCT) in the prospective implementation cohort. Endoscopy with histopathology, when available, served as the reference standard.
Time frame: During the study period (March 2026 to June 2026)
Yield of Clinically Actionable Lesions
Patient-level yield of clinically actionable small gastrointestinal lesions detected in consecutive patients undergoing routine contrast-enhanced photon-counting CT (PCCT) in clinical practice. Clinically actionable lesions were defined based on endoscopic or histopathological confirmation when available.
Time frame: During the study period (March 2026 to June 2026)
Lesion-to-Mucosa Attenuation Difference
Difference in attenuation between gastrointestinal lesions and adjacent normal mucosa measured on 40-keV virtual monoenergetic images from photon-counting CT.
Time frame: During the study period (January 2026 - March 2026)
Image Noise
Image noise will be defined as the standard deviation of CT attenuation values within a predefined region of interest in the target tissue or reference region. Image noise will be measured separately on photon-counting CT and dual-energy CT images. Lower values indicate lower image noise.
Time frame: During the study period (January 2026 - March 2026)
Signal-to-Noise Ratio
The signal-to-noise ratio will be calculated as the mean CT attenuation value of the target tissue divided by image noise. SNR will be calculated separately for photon-counting CT and dual-energy CT images. Higher values indicate better signal relative to image noise.
Time frame: During the study period (January 2026 - March 2026)
Contrast-to-Noise Ratio
The contrast-to-noise ratio will be calculated as the absolute difference between the mean CT attenuation values of the target tissue and the reference tissue divided by image noise. CNR will be calculated separately for photon-counting CT and dual-energy CT images. Higher values indicate greater contrast relative to image noise.
Time frame: During the study period (January 2026 - March 2026)
Subjective Image Quality Score
Two radiologists, blinded to the clinical, endoscopic, and histopathologic findings, will independently evaluate the image quality of photon-counting CT and dual-energy CT images using a predefined 5-point ordinal scale. Scores range from 1 to 5, with higher scores indicating better subjective image quality.
Time frame: During the study period (January 2026 - March 2026)
Interobserver Agreement for Lesion Detection
Agreement between two radiologists regarding the presence or absence of gastrointestinal lesions on CT images will be assessed using Cohen's kappa coefficient. Kappa values range from -1 to 1, with higher values indicating better interobserver agreement. Agreement will be evaluated separately for photon-counting CT and dual-energy CT.
Time frame: During the study period (January 2026 - June 2026)
Interobserver Agreement for Lesion Size Measurement
Agreement between two radiologists for measurements of the maximal lesion diameter will be assessed using the intraclass correlation coefficient. Intraclass correlation coefficient values range from 0 to 1, with higher values indicating better interobserver agreement. Agreement will be evaluated separately for photon-counting CT and dual-energy CT.
Time frame: During the study period (January 2026 - June 2026)
Interobserver Agreement for Diagnostic Confidence
Agreement between two radiologists for ordinal diagnostic confidence ratings will be assessed using the weighted kappa coefficient. Weighted kappa values range from -1 to 1, with higher values indicating better interobserver agreement. Agreement will be evaluated separately for photon-counting CT and dual-energy CT.
Time frame: During the study period (January 2026 - March 2026)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.